Invesco’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,319
| Closed | -$11.5K | – | 4031 |
|
|
2022
Q4 | $11.5K | Sell |
10,319
-183,177
| -95% | -$203K | ﹤0.01% | 3974 |
|
|
2022
Q3 | $452K | Buy |
193,496
+3,323
| +2% | +$7.76K | ﹤0.01% | 3276 |
|
|
2022
Q2 | $576K | Buy |
190,173
+179,406
| +1,666% | +$543K | ﹤0.01% | 3240 |
|
|
2022
Q1 | $73K | Buy |
10,767
+579
| +6% | +$3.93K | ﹤0.01% | 3858 |
|
|
2021
Q4 | $86K | Sell |
10,188
-2,330
| -19% | -$19.7K | ﹤0.01% | 3885 |
|
|
2021
Q3 | $93K | Buy |
12,518
+1,370
| +12% | +$10.2K | ﹤0.01% | 3918 |
|
|
2021
Q2 | $76K | Buy |
+11,148
| New | +$76K | ﹤0.01% | 3896 |
|
|
2021
Q1 | – | Sell |
-12,792
| Closed | -$89K | – | 3923 |
|
|
2020
Q4 | $89K | Sell |
12,792
-76,120
| -86% | -$530K | ﹤0.01% | 3617 |
|
|
2020
Q3 | $726K | Sell |
88,912
-141,380
| -61% | -$1.15M | ﹤0.01% | 2948 |
|
|
2020
Q2 | $1.59M | Buy |
+230,292
| New | +$1.59M | ﹤0.01% | 2574 |
|
|
2020
Q1 | – | Sell |
-117,169
| Closed | -$1.02M | – | 3698 |
|
|
2019
Q4 | $1.02M | Buy |
+117,169
| New | +$1.02M | ﹤0.01% | 2964 |
|